Verastem, Inc. VSTM
7.74
(0.06)
(0.77%)
as of 25 Sep
- Market cap
- $694.6M
- P/E
- 0.0×
Follow VSTM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
24.87 | 13.08 | 10.51 | 4.37 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(17.84) | (17.86) | (10.00) | (8.71) | |
P/B ratio |
0.00 | 9.35 | 6.37 | 7.65 | |
Price to Tangible BV |
0.00 | 13.12 | 7.94 | 11.21 | |
EV/Sales |
22.96 | 10.17 | 8.52 | 3.77 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.49) | (3.03) | (2.80) | (2.03) | |
EV/FCF |
(4.49) | (3.03) | (2.80) | (2.03) | |
Quick Ratio |
2.42 | 2.96 | 2.87 | 2.12 | |
Current Ratio |
2.58 | 3.09 | 3.04 | 2.25 | |
Net Debt/EBITDA |
1.47 | 3.12 | 2.43 | 1.92 | |
Debt/Assets |
44.17% | 30.97% | 32.10% | 35.72% | |
Debt/Equity |
(5.03) | 1.33 | 0.89 | 1.48 | |
Asset Turnover |
0.17 | 0.24 | 0.28 | 0.43 | |
Operating CF/Net income |
0.37 | 0.91 | 1.42 | 1.27 | |
Capex/Depreciation |
(30.22) | (4.82) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
257.86% | 180.62% | 204.69% | 103.14% | |
Selling, General and Administrative Expense of Revenue |
186.87% | 139.42% | 119.43% | 68.39% | |
Intangible Assets out of Total Assets |
0.09 | 0.07 | 0.07 | 0.08 | |
Share Based Compensation of Revenue |
19.37% | 11.55% | 10.96% | 8.56% | |
Graham Net Nets |
(0.06) | 0.06 | 0.11 | 0.05 | |
Graham Number |
4.47 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(47.49%) | (40.03%) | (47.17%) | (64.40%) | |
Free Cash Flow Yield |
(20.54%) | (25.70%) | (28.98%) | (42.42%) | |
Revenue per Share |
0.15 | 0.25 | 0.19 | 0.40 | |
Operating CF per Share |
(0.49) | (0.43) | (0.53) | (0.44) | |
Capex per Share |
(0.11) | (0.02) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.61) | (0.45) | (0.53) | (0.44) | |
Cash per Share |
1.88 | 2.96 | 1.85 | 1.36 | |
Shareholders Equity per Share |
(0.21) | 0.83 | 0.83 | 0.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.21) | 0.83 | 0.83 | 0.50 | |
Free Cash Flow |
(44.49) | (31.30) | (52.12) | (43.91) | |
Working Capital |
94.34 | 151.15 | 136.06 | 98.03 | |
Capital Expenditures |
(8.28) | (1.34) | — | — | |
Net Current Asset Value |
(38.32) | 34.17 | 56.87 | 19.63 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.74 | 0.08 | 0.00 | 0.00 | |
Net Profit Margin |
(876.34%) | (187.72%) | (195.98%) | (86.51%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.56 | 4.61 | 5.28 | 15.68 | |
Average Payables |
7.16 | 8.24 | 8.40 | 13.02 | |
Average Inventory |
3.08 | 4.07 | 4.30 | 1.78 | |
Average Assets |
151.62 | 173.99 | 179.75 | 201.39 | |
Average Common Equity |
(2.23) | 14.15 | 24.67 | 43.02 |
Columns are period end dates